Individual differences in prefrontal cortex function and the transition from drug use to drug dependence
about
Mindfulness training targets neurocognitive mechanisms of addiction at the attention-appraisal-emotion interfaceComorbidities and continuities as ontogenic processes: Toward a developmental spectrum model of externalizing psychopathologyPrecision in Addiction Care: Does It Make a Difference?Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addictionMolecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disordersAnimal models of post-traumatic stress disorder and recent neurobiological insights.Memory impairment and alterations in prefrontal cortex gamma band activity following methamphetamine sensitization.A unifying model of the role of the infralimbic cortex in extinction and habits.Mechanisms underlying sleep-wake disturbances in alcoholism: focus on the cholinergic pedunculopontine tegmentum.Addictions Neuroclinical Assessment: A reverse translational approach.Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivityGenetic analysis of the neurosteroid deoxycorticosterone and its relation to alcohol phenotypes: identification of QTLs and downstream gene regulation.Neural correlates of substance abuse: reduced functional connectivity between areas underlying reward and cognitive control.Differential sensitivity of prefrontal cortex and hippocampus to alcohol-induced toxicity.A psycho-genetic study of hedonic responsiveness in relation to "food addiction".Weak ventral striatal responses to monetary outcomes predict an unwillingness to resist cigarette smoking.Neuroscience of behavioral and pharmacological treatments for addictionsThe missing p in psychiatric training: why it is important to teach pain to psychiatrists.Functional connectivity in frontal-striatal brain networks and cocaine self-administration in female rhesus monkeys.Feeding and reward: perspectives from three rat models of binge eating.What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.Brain perfusion in polysubstance users: relationship to substance and tobacco use, cognition, and self-regulation.Prenatal Stress Alters Progestogens to Mediate Susceptibility to Sex-Typical, Stress-Sensitive Disorders, such as Drug Abuse: A Review.Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking.Activation of the medial prefrontal cortex by escapable stress is necessary for protection against subsequent inescapable stress-induced potentiation of morphine conditioned place preference.Take it or leave it: prefrontal control in recreational cocaine usersAggression and increased glutamate in the mPFC during withdrawal from intermittent alcohol in outbred miceNeurocognitive performance in drug-dependent males and females with posttraumatic stress disorder symptomsCue-elicited heart rate variability and attentional bias predict alcohol relapse following treatmentInvestigating Maternal Brain Structure and its Relationship to Substance Use and Motivational SystemsTheoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.Medications development to treat alcohol dependence: a vision for the next decade.Interactive effects of chronic cigarette smoking and age on brain volumes in controls and alcohol-dependent individuals in early abstinenceMulti-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.Control of craving by the prefrontal cortex.Alcohol dependence as a chronic pain disorderAAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessationPatient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.
P2860
Q21129105-EE9CCD30-6BD4-44CF-B47E-58FCAC02F472Q22061930-0072CFFC-A9C8-4A51-AD08-B64E154381A0Q26775801-A6105B9E-38F1-45CD-8B74-1916FE65D593Q26824038-5337274C-8065-4091-A25D-F74770493E79Q26853035-6D436037-4C84-4DA5-978C-521FB739F07AQ26864330-A498BD82-AC27-433B-84BE-D95C37EC441FQ27324845-AE629A60-45E1-4794-8348-DC4D020A2ACFQ27687716-029898BD-EA16-40D0-A6E8-0D71F94F1D1DQ30399710-8A6EA186-8CF4-4ADE-9F01-27E61FEA3621Q30399803-5DB772F2-5CF4-4C51-BED9-20B6CF5A21A9Q30422045-8929382B-BD72-46EB-88BE-31750F08242BQ33873603-A4F5A810-6BEA-4BAE-83EC-8AC48639640AQ33934564-ED74E21F-F570-45B2-81E8-15094DE506D8Q34134199-C0B8028E-1F76-4360-9EDA-D6BEFEF97F4AQ34411692-9D6840B0-0994-413B-990A-F2F07991B10EQ34422430-CADD6AD0-7DA2-4312-B6DD-393C84302A9AQ34714494-13993320-30E3-404F-843C-D2280C73BF66Q34894116-857AE29B-D7FC-473E-94CF-E49E60B15254Q35027847-42F06E88-2CA1-498E-A15D-B062EEFF62D1Q35093247-FF7AACF5-2FAA-473B-8259-9A2B4ED4FAA2Q35195505-D5E7A816-CB0F-4606-99A4-7EDA533EF37DQ35225923-E592798B-52BA-4335-9737-EDBC2AE18C81Q35287414-7629E05D-B182-4E0D-9418-BDF7D4ACCDF4Q35367349-3728B5F2-FEA2-4BB7-9799-C99E99B297FDQ35423832-7797BBE6-A9A9-4D30-AD36-82CB5A8FE260Q35652871-EBA2DD15-0B87-44CE-AA56-75A31FFCCD61Q35813160-34113316-EFC4-496C-993E-B4040E96A7C0Q35889443-845AFEE4-CBB3-40D8-8732-76DDD7DA4367Q35915702-996B9003-C672-462C-B5D2-51CD31A8D854Q35942169-A709D329-70B8-4C7F-9E7A-ADD30AC14EFFQ36007745-553318DC-809B-4598-98B6-BF63714FF062Q36253073-0421DEF3-F5BC-40D9-A486-D64A04701945Q36357552-51549ADD-A10E-4E24-A198-24AA8764E615Q36484347-6E1F9433-8FC9-4FFD-9FB3-F6A3BE6285D2Q36588615-1BB9C14E-60A9-4606-B0F6-9118FC915E20Q36692770-C90D0B77-0562-480F-969A-B61CD96B945DQ36730512-11C3A75B-5364-4F07-A861-A4CB8342823DQ36756701-A7B0D064-6AC4-44CC-BF03-0055087BBBCCQ36800122-594F35C5-A033-4FB8-B1F0-F569CC886EA5Q36852840-F343C387-C61B-49ED-AF52-0AB3F1310FFD
P2860
Individual differences in prefrontal cortex function and the transition from drug use to drug dependence
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Individual differences in pref ...... om drug use to drug dependence
@ast
Individual differences in pref ...... om drug use to drug dependence
@en
Individual differences in pref ...... om drug use to drug dependence
@nl
type
label
Individual differences in pref ...... om drug use to drug dependence
@ast
Individual differences in pref ...... om drug use to drug dependence
@en
Individual differences in pref ...... om drug use to drug dependence
@nl
prefLabel
Individual differences in pref ...... om drug use to drug dependence
@ast
Individual differences in pref ...... om drug use to drug dependence
@en
Individual differences in pref ...... om drug use to drug dependence
@nl
P2860
P1476
Individual differences in pref ...... om drug use to drug dependence
@en
P2093
George F Koob
P2860
P304
P356
10.1016/J.NEUBIOREV.2010.05.002
P577
2010-05-20T00:00:00Z